R&D News | pharmaphorum

News

A project to use federal databases to identify the "root causes of autism" has been launched by HHS, but there are concerns about its credibility.

News

AstraZeneca and Daiichi Sankyo's Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage breast cancer for the first time.

News

An AI model is being piloted at a national scale for the first time, but will it be able to predict future health risks reliably?

News

Eli Lilly has added another candidate to a growing pipeline of therapies for ALS, tapping Alchemab for an antibody sourced from 'resilient' patients.

News

The EU has announced a €500m scheme to convince scientific talent from around the world to relocate to Europe's "free and open" research environment.

News

In a potentially pivotal trial, PTC Therapeutics' therapy for Huntington's disease met its primary endpoint, but there are questions about the data.